Total Funding
66
67
Total FundingSeries B raised
Growth Score
-2 pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
41625
Epic Bio's strength is a relentless focus on ushering in a new era of gene regulation.
- Stanley Qi: FounderPast Role: University of California, San Francisco, Systems Biology Faculty Fellow
- Amber Salzman: CEOPast Role: Ohana Biosciences, President & CEO
About the Company
The Gene Expression Modulation System (GEMS) technology from Epic-Bio combines a DNA-binding protein, a tailored guide RNA, and any of a wide range of modulator proteins to generate a powerful new type of genetic medicine. GEMS medicines have the ability to precisely modify gene expression both in and out of the body. They are mutation-independent,
which means that a single GEMS design can address the majority or all genetic subtypes of a disease.
